Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionXponance, Inc.
Latest Disclosed Ownership4,507 shares
Latest Disclosed Value $ 688,444
Xponance, Inc. reports 27.10% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Xponance, Inc. filed a 13F-HR form disclosing ownership of 4,507 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $579,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 3,546 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 27.10% during the quarter. The current value of the position is $545,347 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,507 961 27.10 688 40.98 0.0049
2026-02-12 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,546 367 11.54 489 19.90 0.0037
2025-11-12 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,179 408 14.72 408 21.49 0.0032
2025-08-14 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,771 46 1.69 335 10.56 0.0028
2025-05-01 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,725 125 4.81 304 19.76 0.0029
2025-02-11 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,600 131 5.31 253 -10.60 0.0023
2024-11-12 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,469 277 12.64 284 21.46 0.0027
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,192 2,192 233 0.0024
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.